Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Masako Yamasaki"'
Autor:
Wakana Saso, Masako Yamasaki, Shin-Ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, Nongluk Sriwilaijaroen, Osamu Kanie, Masamichi Muramatsu, Yoshimasa Takahashi, Tetsuro Matano, Makoto Takeda, Yasuo Suzuki, Koichi Watashi
Publikováno v:
PLoS Pathogens, Vol 18, Iss 6, p e1010590 (2022)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been transmitted across all over the world, in contrast to the limited epidemic of genetically- and virologically-related SARS-CoV. However, the molecular basis explaining the differenc
Externí odkaz:
https://doaj.org/article/6b10f0b116944715b5ff408429413a95
Autor:
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita, Koichi Watashi
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon w
Externí odkaz:
https://doaj.org/article/04c84a66c3fc4820b9e215e12bd83143
Autor:
Chisa Kobayashi, Yoshihiro Watanabe, Mizuki Oshima, Tomoyasu Hirose, Masako Yamasaki, Masashi Iwamoto, Masato Iwatsuki, Yukihiro Asami, Kouji Kuramochi, Kousho Wakae, Hideki Aizaki, Masamichi Muramatsu, Camille Sureau, Toshiaki Sunazuka, Koichi Watashi
Publikováno v:
Viruses, Vol 14, Iss 4, p 764 (2022)
Current anti-hepatitis B virus (HBV) drugs are suppressive but not curative for HBV infection, so there is considerable demand for the development of new anti-HBV agents. In this study, we found that fungus-derived exophillic acid inhibits HBV infect
Externí odkaz:
https://doaj.org/article/9670e2105fe742b1a5396a01e8c5fe35
Autor:
Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, Michiyo Kataoka, Masako Yamasaki, Kouji Kuramochi, Masamichi Muramatsu, Tadaki Suzuki, Camille Sureau, Makoto Takeda, Takaji Wakita, Farhad Parhami, Koichi Watashi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6, p 3163 (2021)
The development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is urgently needed to combat the coronavirus disease 2019 (COVID-19). We have previously studied the use of semi-synthetic
Externí odkaz:
https://doaj.org/article/a998174f28e94e449274955719896c32
Autor:
Kou Nakamura, Masako Yamasaki, Hirofumi Ohashi, Shiki Saito, Koudai Ashikawa, Kanna Sato, Kazane Nishioka, Yuka Suzuki, Yukine Tsurukawa, Kazuki Kanno, Nozomi Mosu, Hironobu Murakami, Masaki Nagane, Maiko Okada, Koichi Watashi, Shinji Kamisuki
Publikováno v:
Chemical and Pharmaceutical Bulletin.
Autor:
Kota Nishiuchi, Hirofumi Ohashi, Kazane Nishioka, Masako Yamasaki, Masateru Furuta, Takumi Mashiko, Shusuke Tomoshige, Kenji Ohgane, Shinji Kamisuki, Koichi Watashi, Kouji Kuramochi
Publikováno v:
Journal of Natural Products
We have previously reported that neoechinulin B (1a), a prenylated indole diketopiperazine alkaloid, shows antiviral activities against hepatitis C virus (HCV) via the inactivation of the liver X receptors (LXRs) and the resultant disruption of doubl
Autor:
Wakana Saso, Masako Yamasaki, Shin-ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, Nongluk Sriwilaijaroen, Osamu Kanie, Masamichi Muramatsu, Yoshimasa Takahashi, Tetsuro Matano, Makoto Takeda, Yasuo Suzuki, Koichi Watashi
Publikováno v:
PLoS pathogens. 18(6)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been transmitted across all over the world, in contrast to the limited epidemic of genetically- and virologically-related SARS-CoV. However, the molecular basis explaining the differenc
Autor:
Kouji Kuramochi, Tadaki Suzuki, Camille Sureau, Farhad Parhami, Wakana Saso, Masamichi Muramatsu, Takaji Wakita, Chisa Kobayashi, Masako Yamasaki, Feng Wang, Kana Tsuchimoto, Michiyo Kataoka, Koichi Watashi, Makoto Takeda, Hirofumi Ohashi, Frank Stappenbeck
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 3163, p 3163 (2021)
Volume 22
Issue 6
International Journal of Molecular Sciences, Vol 22, Iss 3163, p 3163 (2021)
Volume 22
Issue 6
The development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is urgently needed to combat the coronavirus disease 2019 (COVID-19). We have previously studied the use of semi-synthetic
Autor:
Shoya Iwanami, Koichi Watashi, Kaho Shionoya, Yusuke Ito, Makoto Takeda, Tomohiro Tanaka, Shuetsu Fukushi, Masamichi Muramatsu, Takaji Wakita, Wakana Saso, Masako Yamasaki, Shingo Iwami, Shin Aoki, Hirofumi Ohashi, Yoshimasa Takahashi, Kouji Kuramochi, Tadaki Suzuki
Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f3bd69ff7dcf0732f7cda54939c19e
https://doi.org/10.1101/2020.11.19.389726
https://doi.org/10.1101/2020.11.19.389726
Autor:
Masahisa Inoue, Noriyuki Nagai, Katsumi Nishijima, Nobuyoshi Takeshita, Chofuku Hoh, Hitoshi Nagatsuka, Masako Yamasaki, Tetsudo Nojima
Publikováno v:
Journal of Oral Pathology and Medicine. 20:460-463
The histologic classification for odontogenic carcinomas is still under revision; thus, the differentiation between the terms "malignant ameloblastoma" and "ameloblastic carcinoma" has not been definitely stated. Nevertheless, it is recommended to re